Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adrenoceptor beta 1 | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 1.1 m equiv kg-1 | Saluretic activity was evaluated for K+ by flame photometry at 8 mg/kg perorally | ChEMBL. | 8093626 |
Activity (functional) | = 1.2 m equiv kg-1 | Saluretic activity was evaluated for K+ by flame photometry at 30 mg/kg perorally | ChEMBL. | 8093626 |
Activity (functional) | = 1.3 m equiv kg-1 | Saluretic activity was evaluated for K+ by flame photometry at 15 mg/kg perorally | ChEMBL. | 8093626 |
Activity (functional) | = 2.1 m equiv kg-1 | Saluretic activity was evaluated for Na+ by flame photometry at 8 mg/kg perorally | ChEMBL. | 8093626 |
Activity (functional) | = 2.2 m equiv kg-1 | Saluretic activity was evaluated for Na+ by flame photometry at 30 mg/kg perorally | ChEMBL. | 8093626 |
Activity (functional) | = 2.6 m equiv kg-1 | Saluretic activity was evaluated for Na+ by flame photometry at 15 mg/kg perorally | ChEMBL. | 8093626 |
ED50 (functional) | = 0.96 mg kg-1 | Beta-adrenoceptor blocking activity after intravenous dose as inhibition of isiprenaline-induced tachycardia in rats | ChEMBL. | 8093626 |
ED50 (functional) | = 0.96 mg kg-1 | Beta-adrenoceptor blocking activity after intravenous dose as inhibition of isiprenaline-induced tachycardia in rats | ChEMBL. | 8093626 |
ED50 (functional) | = 56.37 mg kg-1 | beta-adrenoceptor blocking activity of the perorally administered compound was evaluated by inhibition of isiprenaline-induced tachycardia in rats | ChEMBL. | 8093626 |
ED50 (functional) | = 56.37 mg kg-1 | beta-adrenoceptor blocking activity of the perorally administered compound was evaluated by inhibition of isiprenaline-induced tachycardia in rats | ChEMBL. | 8093626 |
Ki (binding) | = 7.8 nM | Inhibition of [3H]-Dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes. | ChEMBL. | 8093626 |
Ki (binding) | = 7.8 nM | Inhibition of [3H]-Dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes. | ChEMBL. | 8093626 |
Ratio (functional) | = 1.8 | Ratio of saluretic activity for Na+ over saluretic activity of K+ in rats after peroral administration of 30 mg/kg of compound | ChEMBL. | 8093626 |
Ratio (functional) | = 1.9 | Ratio of saluretic activity for Na+ over saluretic activity of K+ in rats after peroral administration of 8 mg/kg of compound | ChEMBL. | 8093626 |
Ratio (functional) | = 2 | Ratio of saluretic activity for Na+ over saluretic activity of K+ in rats after peroral administration of 15 mg/kg of compound | ChEMBL. | 8093626 |
Urinary output (functional) | = 2.6 ml | Diuretic activity given as urinary output of 8 mg/kg perorally administered compound in rats | ChEMBL. | 8093626 |
Urinary output (functional) | = 3.1 ml | Diuretic activity given as urinary output of 30 mg/kg perorally administered compound in rats | ChEMBL. | 8093626 |
Urinary output (functional) | = 3.3 ml | Diuretic activity given as urinary output of 15 mg/kg perorally administered compound in rats | ChEMBL. | 8093626 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.